BIT Capital’s Cullinan Oncology CGEM Stock Holding History

BIT Capital’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-94,344	Closed	-$1.15M	–	120
2024 Q4	$1.15M	Buy	+94,344	New	+$1.36M	0.09%	67

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT Capital's CGEM Position: Q1 2025 in Review

BIT Capital sold out of Cullinan Oncology (CGEM) in Q1 2025, closing a stake of 94,344 shares — an estimated $1.15M sold.

BIT Capital first reported a position in CGEM in Q4 2024 and held it in 1 quarter. The position peaked at $1.15M in Q4 2024. 148 funds tracked by Wall St. Rank hold CGEM as of Q1 2025.

BIT Capital reported no remaining Cullinan Oncology position as of Q1 2025 after selling out during the quarter.
BIT Capital sold 94,344 Cullinan Oncology shares in Q1 2025, an estimated $1.15M.
BIT Capital first reported a position in Cullinan Oncology in Q4 2024 and held it in 1 quarter.
BIT Capital's Cullinan Oncology position peaked at $1.15M in Q4 2024.
148 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.